Aurinia Pharmaceuticals AUPH Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Aurinia Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 6:06 AM EST
- Fiscal year
- FY2025
- Accession
- 0001600620-26-000017
| --- | --- | --- | | ASSETS | | | | Other current liabilities | 2,480 | 1,531 | | Total current liabilities | 93,724 | 97,763 | | Finance lease liabilities, less current portion | 52,322 | 58,554 | | Deferred revenue, less current portion | 12,648 | 1,699 | | Deferred compensation and other noncurrent liabilities | 6,662 | 9,408 | | Operating lease liabilities, less current portion | 4,900 | 5,743 | | Total liabilities | 170,256 | 173,167 | | Commitments and contingencies (Note 5) | | |
Item 16. Form 10-K Summary.
FAQ
- What is Aurinia Pharmaceuticals's contract liabilities, non-current?
- Aurinia Pharmaceuticals (AUPH) reported contract liabilities, non-current of $12.65M in Q4 2025.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about Aurinia Pharmaceuticals's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
